Stocky turns companies like MEDIX INC into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. 331A.T scores middling on both growth (55.5) and value (52) dimensions, indicating neither a compelling compounder nor a deep-value opportunity. Leadership Alignment at 45/100 suggests meaningful misalignment between management and shareholders—likely reflected in dilutive capital allocation or founder-CEO separation—that undermines conviction. Vulnerability remains unassessed, leaving structural risks opaque. Hold until either operational execution improves materially or management in
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for MEDIX INC:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 52/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates MEDIX INC (331A.T) at 52/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. 331A.T scores middling on both growth (55.5) and value (52) dimensions, indicating neither a compelling compounder nor a deep-value opportunity. Leadership Alignment at 45/100 suggests meaningful misalignment between management an
331A.T's current Stocky Verdict is 52/100, placing it in the "Cautious" band. This composite combines a 56/100 Compounder score, 45/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for MEDIX INC yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
MEDIX INC scores 45/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
Vulnerability Profile for MEDIX INC covers customer concentration, supply chain risk, refinancing walls, and regulatory exposure. Not yet finalised.
Sign up free and unlock the full analysis on 331A.T — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 331A.T in the app.
